GREY:ICOTF - Post by User
Comment by
zoomzoom3on Jul 22, 2014 9:17pm
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
197 Views
Post# 22772011
RE:Immune shares up a big 8.29% Today
RE:Immune shares up a big 8.29% Today
Never mind I found it myself and have copy and pasted below from June 24 2011. iCo Therapeutics Executes Bertilimumab License with Immune Pharmaceuticals iCo Therapeutics Executes Bertilimumab License with Immune Pharmaceuticals Highlights: - Upfront consideration: • US $500,000 cash • 600,000 IMMUNE shares and 200,000 IMMUNE warrants • A 6.14% ownership stake (fully diluted basis) with preferential share features - US$32 million in milestones plus royalties - License is for systemic uses, iCo retains exclusive rights to all ocular applications - IMMUNE expects to initiate new GMP manufacturing with a leading biologics manufacturer and plan for phase II clinical trials in Inflammatory Bowel Disease.